News
A recent European Patent Office Enlarged Board of Appeal decision G1/23 has clarified that commercially available products form part of the state of the art irrespective of whether the skilled person is able to reproducibly manufacture them...
We are delighted to announce that Dr Peter Marchand has joined the Partnership and are looking forward to him helping us build and grow the firm for the future. Pete joined Williams Powell in July 2024 having previously worked at another private prac...
On 18 June 2025, the European Patent Office's Enlarged Board of Appeal issued their keenly awaited G1/24 decision clarifying the rules of interpretation for patent claims when assessing patentability. The Board decided that the "descriptio...
The recent EPO appeal decision T0589/22 discusses the requirement of plausibility in a diagnostic method case, but also provides a cautionary tale regarding defining a patient group in a claim. At the European Patent Office, for a therapeutic ap...
The European Patent Office has announced that the validation agreement with Laos signed in May 2024 will enter into force on 1 April 2025. From this date, it will be possible to obtain protection in 46 countries by means of a single Europe...
©
2007 - 2025
Williams Powell
All rights reserved.
Williams Powell are regulated by IPREG whose code of conduct can be found here.These pages aim to provide a source of information for both non-professional enquirers e.g. inventors and their companies in the U.K. and professional consultants and advisers throughout the rest of the world. The pages are not intended to provide legal advice, which will only be provided on direct application to us in the formal context of a client/attorney relationship.
The information provided is correct to the best of our knowledge and belief, but is provided without obligation or guarantee. It will be updated from time to time as needed.